Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 671

1.

Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.

Tewawong N, Vichiwattana P, Korkong S, Klinfueng S, Suntronwong N, Thongmee T, Theamboonlers A, Vongpunsawad S, Poovorawan Y.

PLoS One. 2017 Apr 14;12(4):e0175655. doi: 10.1371/journal.pone.0175655. eCollection 2017.

2.

Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.

Neri-Bazán RM, García-Machorro J, Méndez-Luna D, Tolentino-López LE, Martínez-Ramos F, Padilla-Martínez II, Aguilar-Faisal L, Soriano-Ursúa MA, Trujillo-Ferrara JG, Fragoso-Vázquez MJ, Barrón BL, Correa-Basurto J.

Eur J Med Chem. 2017 Mar 10;128:154-167. doi: 10.1016/j.ejmech.2017.01.039. Epub 2017 Jan 24.

PMID:
28182988
3.

Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.

Kossyvakis A, Mentis AA, Tryfinopoulou K, Pogka V, Kalliaropoulos A, Antalis E, Lytras T, Meijer A, Tsiodras S, Karakitsos P, Mentis AF.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):361-371. doi: 10.1007/s10096-016-2809-3. Epub 2016 Nov 15.

PMID:
27848039
4.

The pharmacological management of severe influenza infection - 'existing and emerging therapies'.

Mc Mahon A, Martin-Loeches I.

Expert Rev Clin Pharmacol. 2017 Jan;10(1):81-95. doi: 10.1080/17512433.2017.1255550. Epub 2016 Nov 25. Review.

PMID:
27797595
5.

Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.

Das A, Adak AK, Ponnapalli K, Lin CH, Hsu KC, Yang JM, Hsu TA, Lin CC.

Eur J Med Chem. 2016 Nov 10;123:397-406. doi: 10.1016/j.ejmech.2016.07.064. Epub 2016 Jul 28.

PMID:
27487569
6.

ECDC public consultation on the use of neuraminidase inhibitors.

Eurosurveillance editorial team..

Euro Surveill. 2016;21(7):pii=30140. No abstract available.

PMID:
27358927
7.

Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.

Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Kuwahara T, Shimazu Y, Shimomura T, Watanabe S, Odagiri T; Influenza Virus Surveillance Group of Japan..

Euro Surveill. 2016 Jun 16;21(24). doi: 10.2807/1560-7917.ES.2016.21.24.30258.

8.

Kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza.

Albiñana CB, Machara A, Řezáčová P, Pachl P, Konvalinka J, Kožíšek M.

Eur J Med Chem. 2016 Oct 4;121:100-9. doi: 10.1016/j.ejmech.2016.05.016. Epub 2016 May 7.

PMID:
27236066
9.

Susceptibility of influenza viruses circulating in Western Saudi Arabia to neuraminidase inhibitors.

Tolah AM, Azhar EI, Hashem AM.

Saudi Med J. 2016 Apr;37(4):461-5. doi: 10.15537/smj.2016.4.14837.

10.

Treatment and Prevention of Pandemic H1N1 Influenza.

Rewar S, Mirdha D, Rewar P.

Ann Glob Health. 2015 Sep-Oct;81(5):645-53. doi: 10.1016/j.aogh.2015.08.014. Review.

11.

A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.

Yuan S, Chu H, Singh K, Zhao H, Zhang K, Kao RY, Chow BK, Zhou J, Zheng BJ.

Sci Rep. 2016 Mar 9;6:22880. doi: 10.1038/srep22880.

12.

Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages.

Pawelek KA, Dor D Jr, Salmeron C, Handel A.

PLoS One. 2016 Feb 26;11(2):e0150568. doi: 10.1371/journal.pone.0150568. eCollection 2016.

13.

Characterization of Neuraminidase Inhibitors in Korean Papaver rhoeas Bee Pollen Contributing to Anti-Influenza Activities In Vitro.

Lee IK, Hwang BS, Kim DW, Kim JY, Woo EE, Lee YJ, Choi HJ, Yun BS.

Planta Med. 2016 Apr;82(6):524-9. doi: 10.1055/s-0041-111631. Epub 2016 Feb 5.

PMID:
26848705
14.

Influenza Virus Shedding in Laninamivir-Treated Children upon Returning to School.

Kondo H, Shobugawa Y, Hibino A, Yagami R, Dapat C, Okazaki M, Otsuka T, Fujii K, Hassan MR, Saito R.

Tohoku J Exp Med. 2016;238(2):113-21. doi: 10.1620/tjem.238.113.

15.

Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.

Lin C, Sun C, Liu X, Zhou Y, Hussain M, Wan J, Li M, Li X, Jin R, Tu Z, Zhang J.

Antiviral Res. 2016 May;129:13-20. doi: 10.1016/j.antiviral.2016.01.005. Epub 2016 Jan 21.

PMID:
26802557
16.

Discovery of Novel Pyrazole Derivatives as Potent Neuraminidase Inhibitors against Influenza H1N1 Virus.

Meng FJ, Sun T, Dong WZ, Li MH, Tuo ZZ.

Arch Pharm (Weinheim). 2016 Mar;349(3):168-74. doi: 10.1002/ardp.201500342. Epub 2016 Jan 21.

PMID:
26797880
17.
18.

Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.

Liu Z, Zhao J, Li W, Shen L, Huang S, Tang J, Duan J, Fang F, Huang Y, Chang H, Chen Z, Zhang R.

Sci Rep. 2016 Jan 12;6:19095. doi: 10.1038/srep19095.

19.

H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.

Yusuf M, Mohamed N, Mohamad S, Janezic D, Damodaran KV, Wahab HA.

J Chem Inf Model. 2016 Jan 25;56(1):82-100. doi: 10.1021/acs.jcim.5b00331. Epub 2016 Jan 8.

PMID:
26703840
20.

NAIplot: An opensource web tool to visualize neuraminidase inhibitor (NAI) phenotypic susceptibility results using kernel density plots.

Lytras T, Kossyvakis A, Mentis A.

Antiviral Res. 2016 Feb;126:18-20. doi: 10.1016/j.antiviral.2015.12.002. Epub 2015 Dec 12.

PMID:
26692213

Supplemental Content

Loading ...
Support Center